Notably, the expression of exosomal LBP was higher in patients with metastatic NSCLC than those without metastasis, suggesting exosomal LBP may serve as a potential biomarker for metastasis and distinguish between patients with metastatic and non-metastatic NSCLC [164]. Here, LBP is linked to non-small cell lung carcinoma.